Certain Common Stock of Stoke Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 27-MAY-2024. These Common Stock will be under lockup for 61 days starting from 27-MAR-2024 to 27-MAY-2024.

Details:
The directors, executive officers and certain shareholders have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a period of 60 days after the date of this prospectus supplement, may not, without the prior written consent of J.P. Morgan Securities LLC, (1) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock